Neutralizing activity to SARS-CoV-2 in 1.2 to 10.0 month convalescent plasma samples of COVID-19: A transversal surrogate in vitro study performed in Quito-Ecuador

Article

Abstract: Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (

Palabras claves:

convalescence, IGG, Igm, neutralizing antibodies, Plasma, SARS-COV-2

Autores:

Aguirre M., Armijos D., Burbano M.J., Elius Paz-Cruz, Irina M. Villacrés-Granda, Villacrés-Granda B.

Fuentes:

scopus